India Is Training Doctors for the World, But It Is Pricing Out the Middle Class
India will train a surplus of doctors by the early 2030s. Whether that becomes an export capability or a stranded cohort depends on a price structure that needs targeted remedy. Fees at the top of India's private medical market indicate a desperate flight to quality, and urgent action is needed to protect the talent pipeline.
India measures progress in medical education by counting seats. It is the number ministers cite, the regulator publishes, and the commentary follows, and it has genuinely moved. It is also an incomplete metric. What decides whether a family can put a doctor through the system is not how many seats exist but what they cost, and on that measure the expansion is heading in the wrong direction.
The expansion deserves to be commended first. The National Medical Commission's seat matrix for 2026-27 carries 1,36,939 MBBS seats across 823 colleges, excluding the Institutes of National Importance, of which 9,911 are newly approved this year. Postgraduate seats have reached 86,360 against 31,185 in 2014. On 24 July, 2026, the Health Minister told the Lok Sabha that India's doctor-population ratio now stands at 1:778, finally ahead of the World Health Organization benchmark of 1:1000. On the government's own metric, the historic shortage is finally resolved after a decade of targeted effort.
The composition is where the difficulty sits. Government seats stand at 63,296 against 73,643 in private and deemed institutions, and roughly 79% of this year's addition came from private colleges, so the marginal seat is priced at market. That is a policy consequence. The constraint on public expansion has been teaching-hospital capacity and talent availability, and the result is a radical price increase due to a flight to quality towards the top private medical colleges.
Price Has Diverged From Quality
Fees at the top of the private market are not explained only by what they deliver. A Careers360 analysis of 2026-27 fee structures at 62 deemed-university medical colleges found 46 above Rs 1 crore for the full programme, against 38 of 59 a year earlier. The nine costliest run from Rs 1.36 crore to Rs 1.58 crore, led by Sri Ramachandra Institute in Chennai, and six of the nine are in Tamil Nadu. None of these figures includes hostel or mess.
Ranking does not always track price. Kasturba Medical College Manipal is ranked tenth, and at Rs 71.32 lakh sits in the lowest-fee group of the 62 analysed, less than half what the costliest charge.
The premium buys access to a brand under scarcity, and the desperation of that flight to quality is what keeps the price escalating.
Two colleges show the mechanism. Dhanalakshmi Srinivasan Medical College and Srinivasan Medical College raised annual MBBS fees to Rs 24 lakh and Rs 25 lakh on receiving deemed-university status, from the Rs 5.4 lakh state quota and Rs 16.2 lakh management quota rates permitted when they were self-financing colleges under a state university. A change in regulatory category, with no change in teaching, moved the price more than four-fold. Four more Tamil Nadu colleges took deemed status this year, and the state leads the list of most expensive medical seats in the country due to this mechanism.
Scarcity, once created, acquires defenders. Restricting who could open a medical college was justified as a guard against commercialisation, but it achieved the opposite. Tamil Nadu's own Prohibition of Collection of Capitation Fee Act of 1992 opens by recording that the collection of capitation fees for admission was already widespread in the state, and set a penalty running to seven years in prison. The Madras High Court held as recently as 2022 that such collection remains illegal under that Act. For a generation, a medical seat could be had for cash, which is a perverse method to deliver social justice. Medical education became a classic case of bad policy captured by vested interests, and this denied our youth their right to a decent education at reasonable prices.
Six of the nine costliest deemed-university programmes in the country are in Tamil Nadu, which is also the only state to have twice legislated for exemption from NEET. A policy in the name of the poor became a licence to exploit pricing, and the interests it enriched are the ones most opposed to a national entrance rank and a published fee. Centralised testing and disclosure did not create the price. They are making it visible, which is why they are resisted.
However, price does not move only upward. Amrita School of Medicine in Kochi cut its total fee by about 10% this year. The colleges also have a real argument. Before the Madras High Court, the Education Promotion Society of India submitted that if half of a college's seats are priced at government levels, then the other half must carry the difference. That arithmetic is correct. It is an argument for a published cost-plus formula and a re-rating of the government quota seat allocation and pricing. The General Category students must not pay a disproportionate fee for no fault of theirs.
One Unindexed Threshold Governs Reservation, Relief and Credit
The category structure and the price structure run in opposite directions, and the middle class salaried household is sacrificed at the crossroads. Reservation in the All India Quota totals 59.5%, leaving 40.5% unreserved, while deemed universities carry no caste or income category reservation at all and fill their seats on rank, subject to an NRI quota and, at some institutions, minority quotas. The pool with no category filter is the pool priced above Rs 1 crore in three cases out of four.
This is not an argument about reservation quotas, which are settled constitutional policy, and it is not a claim that reservation caused the price problem. The live question is the threshold that decides who sits inside the system's relief mechanisms, because one classification framework performs unrelated jobs and has been revised to solve none of them.
The creamy layer ceiling for the Other Backward Classes was set at Rs 8 lakh with effect from 1 September 2017 and has not moved since, as the Press Information Bureau records, after earlier revisions took it from Rs 1 lakh in 1993 to Rs 6 lakh in 2013. The ceiling for Economically Weaker Sections has stood at Rs 8 lakh since 2019, and PM-Vidyalaxmi uses the same figure for its interest subvention. Nine years is twice the four to five year cadence that held from 2004 to 2017, and households are now excluded by inflation.
The same number is not even the same test, and the difference falls on the salaried. The creamy layer test leaves out income from salaries and agricultural land. The Economically Weaker Sections test counts every source including salary, and disqualifies any family owning a flat of 1,000 square feet, whatever it earns. The one door open to a general category household is the door that counts its salary and legacy assets in full.
The financing architecture repeats the mismatch. PM-Vidyalaxmi offers collateral-free loans with no ceiling on the amount, which is a real reform. But its risk-sharing does not follow the principle. The credit guarantee covers 75% of default only up to Rs 7.5 lakh, the subvention stops at Rs 10 lakh, and the scheme reaches only institutions on a list built from NIRF rankings, which publish 50 medical institutions, along with central government institutions. Management quota and NRI quota admissions are excluded by design.
A family billed a crore outside that list has neither route, which is why their house gets mortgaged to support a student’s dream to become a doctor.
The Overseas Escape Route Rarely Produces a Practising Doctor
Departure abroad is a price response, and the return pipeline shows this is also failing its core purpose. In the Foreign Medical Graduate Examination of June 2026, only 4,635 of the 36,300 candidates who appeared qualified. The Minister of State for Health put the pass rate at 12.78% in Parliament, noting that around 88% of those who applied were repeat candidates while first-timers passed at above 35%. That session is under review by a committee appointed by the examining board, so no single result carries the argument. The pass rate has stayed inside a band of roughly 5% to 30% for a decade.
Families paying a reported Rs 15 lakh to Rs 45 lakh abroad to avoid a crore-scale seat at home are buying a qualification that fails on first attempt roughly two times in three, per the government's own admission.
Unaffordable pricing in India chases students out of the country, a majority of whom fail the qualification examination when they return.
Price Corrects When Good Colleges Are Allowed to Grow
The first reform is already half done. By gazette notification of 27 April 2026, the Commission deleted the clause restricting a college seeking a seat increase to a maximum intake of 150 MBBS seats, and dropped the 100-seats-per-10-lakh-population norm. The cap is gone, but the expansions that will reduce price have not happened. A college past twenty years with no adverse regulatory finding should be able to raise its intake on certified compliance with faculty and infrastructure norms, rather than on a discretionary inspection. Brownfield expansion where faculty and a teaching hospital already exist is cheaper per seat and better per graduate than a greenfield college in a remote district that can recruit neither. Engineering went through this adjustment. Weak colleges closed, students moved to established institutions with a track record, and prices adjusted.
The second is to recalibrate infrastructure and faculty norms by phase of the course. Under the competency-based curriculum, the first professional year of MBBS is twelve months of anatomy, physiology and biochemistry, taught predominantly in classrooms and laboratories to students who covered much of that ground for NEET already. Norms designed for clinical instruction apply across all five and a half years, loading cost into the period where it least matters. Easing class-size requirements for the pre-clinical phase while holding clinical ratios lowers the cost of a seat without lowering the standard of a doctor. It also explains why the 2023 relaxation of land and bed requirements did not bring fees down. Not all the misplaced norms were eased.
The third reform is to resolve the fee memorandum in one direction or the other. The Commission's memorandum of 3 February 2022, issued under Section 10(1)(i) of the NMC Act, required 50% of seats in private and deemed institutions to be priced at government levels. Three High Courts stayed it, and in January 2024 the Supreme Court took every challenge to itself alongside a writ petition still undecided. The Court has since asked for the same outcome from the other direction, directing in April 2025 that a centralised fee regulation framework be established under the Commission. Sixteen months on, 46 of 62 deemed colleges sit above Rs 1 crore and neither a band nor a framework exists. Either legislate the band or withdraw the memorandum for a published cost-plus formula. A rule that is neither enforced nor withdrawn is worse for both sides than either alternative.
The fourth is to index the Rs 8 lakh income thresholds and publish the rule that governs revision. Statutory indexation on a three-year cycle to nominal per capita income removes the political cost attached to each revision and restores the coverage the threshold carried previously.
The fifth reform is to make a NEET rank rather than an NIRF band the qualifying filter for PM-Vidyalaxmi at medical colleges, and to raise the credit guarantee to a meaningful share of the fee. A national entrance rank is a stricter merit test than an institutional ranking, and the guarantee is what lets a bank lend without a mortgaged house behind it.
The sixth needs no new instrument. In State of Uttar Pradesh versus Bhavna Tiwari, decided on 29 April 2025 in a postgraduate counselling matter, the Supreme Court directed that private and deemed universities must disclose tuition, hostel charges, caution deposits and every miscellaneous charge at the pre-counselling stage. The Commission followed with a notice directing colleges to publish complete fee structures, on pain of penalties and suspension of admissions. A year later, the only usable national picture of MBBS costs came from a counsellor reading 62 fee schedules. Enforce the judgment, and the picture becomes legible to the students.
India Is Heading for a Historic Surplus
The students admitted this year qualify in 2031-32. On present intake, and with the ratio already past the World Health Organization benchmark, India will by then be adding doctors faster than its own demand grows. The question then shifts from shortage to quality.
The World Health Organization has revised its projected global shortfall upward to 11.1 million health workers by 2030. India is already the second largest source of primary medical qualifications on the United Kingdom's register after the United Kingdom itself, and internationally trained doctors make up close to a quarter of the American physician workforce. The supply to demand bridge has been built.
Whether India continues to supply it rests on two pillars not yet fixed. Quality has to be credible at graduation, which is a question about faculty in new colleges rather than seat counts. Price has to fall far enough that the households fuelling the expansion are not excluded from it.
Health Dynamics of India 2022-23 recorded 4,413 specialists in position against 21,964 required at rural community health centres, and that gap has barely moved in a decade. Only 13,232 of those posts have even been sanctioned, so the shortfall is a policy problem before it is a shortage of doctors. Base capacity was added, specialist capacity was not, and the posts to absorb it were never created. A surplus produced on those terms is not an export capability. It is a stranded cohort with a mortgage behind it.
Four of the six reforms ask the State to finish something it has begun, one asks it to enforce judgments it already holds, and only one is new. India has settled how many doctors it can train, and it is about to see that the world will need them. It must now address who, at home, can afford to become one.
This article was first published on Moneycontrol.
DISCLAIMER
Details of all the funds managed by 3one4 capital can be found here: https://www.3one4capital.com/aif-registration-details
For informational purposes only. This content does not constitute an offer to sell or a solicitation of an offer to buy units of any fund. Investments in AIFs involve market risks.
The views expressed herein are those of the author as of the publication date and are subject to change without notice. Neither the author nor any of the entities under the 3one4 Capital Group have any obligation to update the content. This publications are for informational and educational purposes only and should not be construed as providing any advisory service (including financial, regulatory, or legal). It does not constitute an offer to sell or a solicitation to buy any securities or related financial instruments in any jurisdiction. Readers should perform their own due diligence and consult with relevant advisors before taking any decisions. Any reliance on the information herein is at the reader's own risk, and 3one4 Capital Group assumes no liability for any such reliance.Certain information is based on third-party sources believed to be reliable, but neither the author nor 3one4 Capital Group guarantees its accuracy, recency or completeness. There has been no independent verification of such information or the assumptions on which such information is based, unless expressly mentioned otherwise. References to specific companies, securities, or investment strategies are not endorsements. Unauthorized reproduction, distribution, or use of this document, in whole or in part, is prohibited without prior written consent from the author and/or the 3one4 Capital Group.
-p-500.webp)
